Stock CPCI KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Kahira Pharmaceuticals & Chemical Industries Company Share Price

Equities

CPCI

EGS38391C016

Pharmaceuticals

End-of-day quote Egyptian Exchange
Other stock markets
 23:00:00 27/04/2024 BST 		5-day change 1st Jan Change
63.87 EGP 0.00% Intraday chart for Kahira Pharmaceuticals & Chemical Industries Company -9.06% +12.94%
2023 Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
2023 Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023 CI

Financials

Sales 2022 1.11B 23.31M 0 Sales 2023 1.01B 21.07M 0 Capitalization 637M 13.35M 0
Net income 2022 166M 3.48M - Net income 2023 97M 2.03M - EV / Sales 2022 0.45 x
Net cash position 2022 53.52M 1.12M 0 Net Debt 2023 28.62M 600K 0 EV / Sales 2023 0.66 x
P/E ratio 2022
3.33 x
P/E ratio 2023
6.56 x
Employees 2,001
Yield 2022
13.5%
Yield 2023
11.7%
Free-Float 18.53%
More Fundamentals * Assessed data

Chart Kahira Pharmaceuticals & Chemical Industries Company

Dynamic Chart

Latest news about Kahira Pharmaceuticals & Chemical Industries Company

Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2023 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Third Quarter Ended March 31, 2022 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Earnings Results for the Nine Months Ended March 31, 2021 CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Six Months Ended December 31, 2020 CI
Kahira Pharmaceuticals & Chemical Industries Company Reports Unaudited Earnings Results for the First Half of Fiscal Year 2020 CI
Kahira Pharmaceuticals Reports Earnings Results for the Fiscal Year 2019 CI
Cairo Pharmaceuticals Announces Audited Earnings Results for the Nine Months Ended March 31, 2019 CI
Cairo Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018 CI
More news

Press releases Kahira Pharmaceuticals & Chemical Industries Company

Kahira Pharmaceuticals & Chemical Industries : Cairo Pharmaceuticals (CPCI.CA) - Listing Committee Decision PU
Kahira Pharmaceuticals & Chemical Industries : Cairo Pharmaceuticals (CPCI.CA) Reports 6 Months Results PU
More press releases

Quotes and Performance

1 week-9.06%
Current month-9.06%
1 month-9.06%
3 months+2.54%
6 months+49.40%
Current year+12.94%
More quotes

Highs and lows

1 week
63.00
Extreme 63
70.20
1 month
63.00
Extreme 63
72.46
Current year
52.13
Extreme 52.13
83.00
1 year
36.50
Extreme 36.5
83.00
3 years
33.34
Extreme 33.34
83.00
5 years
25.60
Extreme 25.6
83.00
10 years
11.14
Extreme 11.144
83.00
More quotes

Managers and Directors - Kahira Pharmaceuticals & Chemical Industries Company

Managers TitleAgeSince
Yasser Ahmed Farghaly Mohammad CEO
 Chief Executive Officer - 01/06/21
Ahmed Hassan Sabri DFI
 Director of Finance/CFO - -
Medhat Mohammed Hazeen SEC
 Corporate Secretary - -
Members of the board TitleAgeSince
Adel Taha Abdel Wahab CHM
 Chairman - 01/06/21
Yasser Ahmed Farghaly Mohammad CEO
 Chief Executive Officer - 01/06/21
Dina Ismail Ahmed Al Kayyali BRD
 Director/Board Member - 01/06/21
More insiders

Quotes

Date Price Change Volume
28/04/24 63.87 0.00% 1,202
24/04/24 63.87 -9.06% 7,971
23/04/24 70.23 0.00% 3,314
22/04/24 70.23 0.00% 1,721

End-of-day quote Egyptian Exchange, April 27, 2024

More quotes

Company Profile

Cairo Pharmaceuticals specializes in manufacturing and marketing pharmaceutical products for the treatment of inflammatory, infectious, pulmonary, parasitic, dermatological, cardiovascular, allergic diseases, etc. The group also provides veterinary products.
Sector
Pharmaceuticals
More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

1st Jan change Capi.
KAHIRA PHARMACEUTICALS & CHEMICAL INDUSTRIES COMPANY Stock Kahira Pharmaceuticals & Chemical Industries Company
+12.94% 19.91M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. CPCI Stock